406 related articles for article (PubMed ID: 36086920)
1. Multiomics analyses and machine learning of nuclear receptor coactivator 6 reveal its essential role in hepatocellular carcinoma.
Fang Y; Xu Y; Liao W; Ji T; Yu L; Li L; Pan M; Yang D
Cancer Sci; 2023 Jan; 114(1):75-90. PubMed ID: 36086920
[TBL] [Abstract][Full Text] [Related]
2. Nuclear receptor coactivator 6 promotes HTR-8/SVneo cell invasion and migration by activating NF-κB-mediated MMP9 transcription.
Wu L; Zhao KQ; Wang W; Cui LN; Hu LL; Jiang XX; Shuai J; Sun YP
Cell Prolif; 2020 Sep; 53(9):e12876. PubMed ID: 32790097
[TBL] [Abstract][Full Text] [Related]
3. Nuclear receptor coactivator-6 is essential for the morphological change of human uterine stromal cell decidualization via regulating actin fiber reorganization.
Watanabe N; Kawagoe J; Sugiyama A; Takehara I; Ohta T; Nagase S
Mol Reprod Dev; 2022 Apr; 89(4):165-174. PubMed ID: 35384116
[TBL] [Abstract][Full Text] [Related]
4. Nuclear receptor coactivator 6 (NCoA6) promotes cell proliferation, migration, and invasion in pancreatic cancer.
Wang X; Jia Y; Xu X; Hu Y; Fan G; Jing D; Zhang Z; Wang C; Song C; Qin Y; Peng L
Cancer Med; 2023 Sep; 12(17):18425-18439. PubMed ID: 37553876
[TBL] [Abstract][Full Text] [Related]
5. Identification and characterization of the alternatively spliced nuclear receptor coactivator-6 isoforms.
Li Q; Xu J
Int J Biol Sci; 2011 Apr; 7(5):505-16. PubMed ID: 21552418
[TBL] [Abstract][Full Text] [Related]
6. Acidic Microenvironment Up-Regulates Exosomal miR-21 and miR-10b in Early-Stage Hepatocellular Carcinoma to Promote Cancer Cell Proliferation and Metastasis.
Tian XP; Wang CY; Jin XH; Li M; Wang FW; Huang WJ; Yun JP; Xu RH; Cai QQ; Xie D
Theranostics; 2019; 9(7):1965-1979. PubMed ID: 31037150
[No Abstract] [Full Text] [Related]
7. MicroRNA-370 Regulates Cellepithelial-Mesenchymal Transition, Migration, Invasion, and Prognosis of Hepatocellular Carcinoma by Targeting GUCD1.
He Y; He X
Yonsei Med J; 2019 Mar; 60(3):267-276. PubMed ID: 30799589
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-195 regulates steroid receptor coactivator-3 protein expression in hepatocellular carcinoma cells.
Jiang HL; Yu H; Ma X; Xu D; Lin GF; Ma DY; Jin JZ
Tumour Biol; 2014 Jul; 35(7):6955-60. PubMed ID: 24740565
[TBL] [Abstract][Full Text] [Related]
9. Knockout of NCOA5 impairs proliferation and migration of hepatocellular carcinoma cells by suppressing epithelial-to-mesenchymal transition.
He J; Zhang W; Li A; Chen F; Luo R
Biochem Biophys Res Commun; 2018 Jun; 500(2):177-183. PubMed ID: 29626478
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-504 functions as a tumor suppressor in hepatocellular carcinoma through inhibiting Frizzled-7-mediated-Wnt/β-catenin signaling.
Quan H; Li B; Yang J
Biomed Pharmacother; 2018 Nov; 107():754-762. PubMed ID: 30142536
[TBL] [Abstract][Full Text] [Related]
11. Steroid Receptor Coactivator 1 Promotes Human Hepatocellular Carcinoma Progression by Enhancing Wnt/β-Catenin Signaling.
Tong Z; Li M; Wang W; Mo P; Yu L; Liu K; Ren W; Li W; Zhang H; Xu J; Yu C
J Biol Chem; 2015 Jul; 290(30):18596-608. PubMed ID: 26082485
[TBL] [Abstract][Full Text] [Related]
12. Novel miRNA signature for predicting the stage of hepatocellular carcinoma.
Yerukala Sathipati S; Ho SY
Sci Rep; 2020 Sep; 10(1):14452. PubMed ID: 32879391
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-769-5p contributes to the proliferation, migration and invasion of hepatocellular carcinoma cells by attenuating RYBP.
Xian Y; Wang L; Yao B; Yang W; Mo H; Zhang L; Tu K
Biomed Pharmacother; 2019 Oct; 118():109343. PubMed ID: 31545279
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-424-5p acts as a potential biomarker and inhibits proliferation and invasion in hepatocellular carcinoma by targeting TRIM29.
Du H; Xu Q; Xiao S; Wu Z; Gong J; Liu C; Ren G; Wu H
Life Sci; 2019 May; 224():1-11. PubMed ID: 30876939
[TBL] [Abstract][Full Text] [Related]
15. Regulation of Nampt expression by transcriptional coactivator NCOA6 in pancreatic β-cells.
Yoon J; Lee KJ; Oh GS; Kim GH; Kim SW
Biochem Biophys Res Commun; 2017 Jun; 487(3):600-606. PubMed ID: 28435063
[TBL] [Abstract][Full Text] [Related]
16. miR-1307-3p promotes tumor growth and metastasis of hepatocellular carcinoma by repressing DAB2 interacting protein.
Chen S; Wang L; Yao B; Liu Q; Guo C
Biomed Pharmacother; 2019 Sep; 117():109055. PubMed ID: 31176165
[TBL] [Abstract][Full Text] [Related]
17. A cellular senescence-related classifier based on a tumorigenesis- and immune infiltration-guided strategy can predict prognosis, immunotherapy response, and candidate drugs in hepatocellular carcinoma.
Luo Y; Liu H; Fu H; Ding GS; Teng F
Front Immunol; 2022; 13():974377. PubMed ID: 36458010
[TBL] [Abstract][Full Text] [Related]
18. LncRNA H19 promotes the development of hepatitis B related hepatocellular carcinoma through regulating microRNA-22 via EMT pathway.
Li L; Han T; Liu K; Lei CG; Wang ZC; Shi GJ
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5392-5401. PubMed ID: 31298392
[TBL] [Abstract][Full Text] [Related]
19. A single non-synonymous NCOA5 variation in type 2 diabetic patients with hepatocellular carcinoma impairs the function of NCOA5 in cell cycle regulation.
Liu X; Liu F; Gao S; Reske J; Li A; Wu CL; Yang C; Chen F; Luo R; Xiao H
Cancer Lett; 2017 Apr; 391():152-161. PubMed ID: 28137631
[TBL] [Abstract][Full Text] [Related]
20. Multiomics Integration at Single-Cell Resolution Using Bayesian Networks: A Case Study in Hepatocellular Carcinoma.
Jihad M; Yet İ
OMICS; 2023 Jan; 27(1):24-33. PubMed ID: 36602810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
